The global fertility medicines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed to the rising cases of infertility among males as well as females all over the globe. With the rapid rise of the working population and the adoption of a sedentary lifestyle, what has caught pace is the case of infertility all over the globe. As a result of this, the sales of fertility drugs and related services aimed at enhancing the production of sperms and eggs in order to promote fertility among men and women have grown substantially in the past few years. Fertility drugs are the first line of treatment for infertility that works by regulating and stimulating ovulation in women and increasing the sperm count in men.

Further, substantial strategic activities are undertaken by the market players that support the market growth. For instance, in 2019, Ferring Pharmaceuticals, a US-based biopharmaceutical company, acquired US commercialization rights of Ganirelix Acetate Injection from Sun Pharmaceutical Industries Ltd. for an unrevealed amount. With this acquisition, Ferring Pharmaceutical aimed to broaden its medicine portfolio targeted towards reproduction. Ganirelix Acetate Injection was approved by FDA in 2018 and is used to regulate premature luteinizing hormone (LH) levels in women undergoing fertility treatment. Sun Pharmaceutical Industries Ltd is an India-based manufacturer and seller of pharmaceutical formulations and active pharmaceutical ingredients.

Some key players operating in the market include Ferring Pharmaceutical, Merck, Abbott, Bayer AG, and others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape:  Abbott, Merck, Bayer AG, and Ferring Pharmaceuticals.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Fertility Medicines Market - Segmentation

By Drugs 

• Gonadotropin

• Anti-Estrogen

By End-User

• Male

• Female

Global Fertility Medicines Market Segmentation by Region